The split, which had already been announced in the fourth quarter of 2024, is the culmination of a strategic reorientation ...

In an era defined by rapid change and technological disruption, leadership rooted in adaptability, vision, and resilience is ...

Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine.

Mr. Chaiwat Kovavisarach, Group Chief Executive Officer and President of Bangchak Corporation Public Company Limited, shared ...

Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...

"We built Vision X to redefine how content lives in a space,” said Yitzy Shapiro, COO of Blue Square X. "It's not just ...

Outcomes4Me Inc., the developer of the leading, direct-to-patient, AI-driven platform transforming the cancer-care experience, announced today that its German affiliate Outcomes4Me Germany GmbH has ...

Mika's cancer app is a certified medical device clinically proven to help cancer patients cope with both the physical and psychological effects of their diagnosis BOSTON and BERLIN, June ...

As Calum Hood readies to release his debut solo album, he explores how channelling 2000s indie rock and vulnerability informed ‘ORDER chaos ORDER.’ ...

The second phase of a housing conversion project called The Conrad created 36 apartments next to Boston’s Orpheum Theater.